| 000 | 01528 a2200469 4500 | ||
|---|---|---|---|
| 005 | 20250515132455.0 | ||
| 264 | 0 | _c20080828 | |
| 008 | 200808s 0 0 eng d | ||
| 022 | _a0300-8916 | ||
| 024 | 7 |
_a10.1177/030089160809400312 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aJiang, Enli | |
| 245 | 0 | 0 |
_aExpression of CD40 in ovarian cancer and adenovirus-mediated CD40 ligand therapy on ovarian cancer in vitro. _h[electronic resource] |
| 260 |
_bTumori _c |
||
| 300 |
_a356-61 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAdenoviridae |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aAntineoplastic Agents _xadministration & dosage |
| 650 | 0 | 4 |
_aApoptosis _xdrug effects |
| 650 | 0 | 4 |
_aCD40 Antigens _xanalysis |
| 650 | 0 | 4 |
_aCD40 Ligand _xadministration & dosage |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aFlow Cytometry |
| 650 | 0 | 4 | _aGene Expression Regulation, Neoplastic |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aImmunohistochemistry |
| 650 | 0 | 4 | _aIn Situ Nick-End Labeling |
| 650 | 0 | 4 | _aIn Vitro Techniques |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aNeoplasm Staging |
| 650 | 0 | 4 |
_aOvarian Neoplasms _xchemistry |
| 700 | 1 | _aHe, Xiang | |
| 700 | 1 | _aChen, Xiancheng | |
| 700 | 1 | _aSun, Guojuan | |
| 700 | 1 | _aWu, Hongbing | |
| 700 | 1 | _aWei, Yuquan | |
| 700 | 1 | _aZhao, Xia | |
| 773 | 0 |
_tTumori _gvol. 94 _gno. 3 _gp. 356-61 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1177/030089160809400312 _zAvailable from publisher's website |
| 999 |
_c18178380 _d18178380 |
||